{"id":"https://openalex.org/W2052095607","doi":"https://doi.org/10.3987/com-13-12746","title":"Synthesis, Characterization and Suppression of Impurities during Optimization of Dabigatran Etexilate","display_name":"Synthesis, Characterization and Suppression of Impurities during Optimization of Dabigatran Etexilate","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W2052095607","doi":"https://doi.org/10.3987/com-13-12746","mag":"2052095607"},"language":"en","primary_location":{"id":"doi:10.3987/com-13-12746","doi":"https://doi.org/10.3987/com-13-12746","is_oa":true,"landing_page_url":"https://doi.org/10.3987/com-13-12746","pdf_url":null,"source":{"id":"https://openalex.org/S27298842","display_name":"Heterocycles","issn_l":"0385-5414","issn":["0385-5414","1881-0942"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HETEROCYCLES","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.3987/com-13-12746","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100402049","display_name":"Yu Chen","orcid":"https://orcid.org/0000-0002-5115-3600","observed_orcids":["https://orcid.org/0000-0002-5115-3600"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yu Chen","raw_affiliation_strings":["Shanghai AoBo Bio-pharmaceutical Technology Co., Ltd., No.1011, Halei Road, Zhangjiang High-Tech Park, Shanghai 201203, P. R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai AoBo Bio-pharmaceutical Technology Co., Ltd., No.1011, Halei Road, Zhangjiang High-Tech Park, Shanghai 201203, P. R. China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100754782","display_name":"Jun Feng Liang","orcid":"https://orcid.org/0000-0001-7409-7579","observed_orcids":["https://orcid.org/0000-0001-7409-7579"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jun Liang","raw_affiliation_strings":["Shanghai AoBo Bio-pharmaceutical Technology Co., Ltd., No.1011, Halei Road, Zhangjiang High-Tech Park, Shanghai 201203, P. R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai AoBo Bio-pharmaceutical Technology Co., Ltd., No.1011, Halei Road, Zhangjiang High-Tech Park, Shanghai 201203, P. R. China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101419639","display_name":"Huansheng Chen","orcid":"https://orcid.org/0009-0007-4694-5658","observed_orcids":["https://orcid.org/0009-0007-4694-5658"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huansheng Chen","raw_affiliation_strings":["Shanghai AoBo Bio-pharmaceutical Technology Co., Ltd., No.1011, Halei Road, Zhangjiang High-Tech Park, Shanghai 201203, P. R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai AoBo Bio-pharmaceutical Technology Co., Ltd., No.1011, Halei Road, Zhangjiang High-Tech Park, Shanghai 201203, P. R. China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100651678","display_name":"Yuan Li","orcid":"https://orcid.org/0009-0009-4147-1435","observed_orcids":["https://orcid.org/0009-0009-4147-1435"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Li Yuan","raw_affiliation_strings":["Shanghai AoBo Bio-pharmaceutical Technology Co., Ltd., No.1011, Halei Road, Zhangjiang High-Tech Park, Shanghai 201203, P. R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai AoBo Bio-pharmaceutical Technology Co., Ltd., No.1011, Halei Road, Zhangjiang High-Tech Park, Shanghai 201203, P. R. China","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2969,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.59408588,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"87","issue":"8","first_page":"1699","last_page":"1699"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.7925000190734863,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.7925000190734863,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.024000000208616257,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10013","display_name":"Asymmetric Synthesis and Catalysis","score":0.0203000009059906,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dabigatran-etexilate","display_name":"dabigatran etexilate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/impurity-synthesis","display_name":"impurity synthesis","score":0.8159999847412109},{"id":"https://openalex.org/keywords/impurity-characterization","display_name":"impurity characterization","score":0.8569999933242798},{"id":"https://openalex.org/keywords/impurity-suppression","display_name":"impurity suppression","score":0.9660000205039978},{"id":"https://openalex.org/keywords/synthesis-optimization","display_name":"synthesis optimization","score":0.671999990940094}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9162174463272095},{"id":"https://openalex.org/C71987851","wikidata":"https://www.wikidata.org/wiki/Q7216430","display_name":"Impurity","level":2,"score":0.8726769685745239},{"id":"https://openalex.org/C2778810321","wikidata":"https://www.wikidata.org/wiki/Q419345","display_name":"Dabigatran","level":4,"score":0.6766374111175537},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.34523290395736694},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.323474645614624},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.18155324459075928},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.10687357187271118},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.0},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3987/com-13-12746","doi":"https://doi.org/10.3987/com-13-12746","is_oa":true,"landing_page_url":"https://doi.org/10.3987/com-13-12746","pdf_url":null,"source":{"id":"https://openalex.org/S27298842","display_name":"Heterocycles","issn_l":"0385-5414","issn":["0385-5414","1881-0942"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HETEROCYCLES","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3987/com-13-12746","doi":"https://doi.org/10.3987/com-13-12746","is_oa":true,"landing_page_url":"https://doi.org/10.3987/com-13-12746","pdf_url":null,"source":{"id":"https://openalex.org/S27298842","display_name":"Heterocycles","issn_l":"0385-5414","issn":["0385-5414","1881-0942"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HETEROCYCLES","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":3,"referenced_works":["https://openalex.org/W2056612340","https://openalex.org/W2165506983","https://openalex.org/W3189918132"],"related_works":["https://openalex.org/W2320667542","https://openalex.org/W2607862755","https://openalex.org/W2387918948","https://openalex.org/W2378151148","https://openalex.org/W4399439848","https://openalex.org/W2387329566","https://openalex.org/W2387835855","https://openalex.org/W2845401498","https://openalex.org/W3190706608","https://openalex.org/W2169216320"],"abstract_inverted_index":{"The":[0],"synthetic":[1],"methods":[2],"for":[3],"two":[4,15],"impurities":[5,16,27],"of":[6,14,26,34],"dabigatran":[7,35],"etexilate":[8,36],"are":[9,17],"firstly":[10],"described,":[11],"and":[12,21],"both":[13],"characterized":[18],"by":[19],"NMR":[20],"MS":[22],"spectral":[23],"data.The":[24],"suppression":[25],"as":[28,30],"well":[29],"the":[31],"optimization":[32],"process":[33],"is":[37],"also":[38],"disclosed.":[39]},"counts_by_year":[{"year":2017,"cited_by_count":2},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}